mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.2 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |